Supplementary Table 3.
Cohort studies | ||||
---|---|---|---|---|
| ||||
Quality assessment criteria | Acceptable (*) | Berzosa et al. | Sugimoto et al. | Hasan et al. |
Selection | ||||
Representativeness | Population based | |||
Cohort size | Drawn from the same community as exposed cohort | * | * | * |
Clinical outcomes | Secured records, clinical outcomes | * | * | * |
Demonstration that outcome of interest was not present at start of study? | Not present | |||
Comparability | ||||
Factors comparable between groups? | Yes | * | * | * |
Outcome | ||||
Assessment of outcome? | Independent blind assessment, record linkage | * | * | * |
Follow-up time | Mentioned or not mentioned | * | * | * |
Adequacy of follow-up of cohorts? | Complete follow-up, or subjects lost to follow-up unlikely to introduce bias | * | * | * |
Overall quality score | 6 | 6 | 6 | |
| ||||
Randomized control trials | ||||
| ||||
Study quality | Attam et al. | Mok et al. | Wang et al. | |
| ||||
Randomization present | * | * | * | |
Appropriate randomization utilized | * | * | * | |
Blinding present | * | * | * | |
Appropriate blinding method utilized | * | * | * | |
Appropriate long-term follow-up | * | * | * | |
Max score | 5 | 5 | 5 |